Related Experiment Video
Updated: Aug 12, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
Background:
The long-term use of methamphetamine (MAMP) can result in psychosis but it is not clear why some individuals develop psychotic symptoms, while others use MAMP regularly over long periods and remain unscathed. We set out to characterize MAMP users and to examine the relationship of pre-morbid personality, pre-morbid social function and other psychiatric disorders to MAMP psychosis.
Method:
Four hundred and forty-five amphetamine users were recruited from a psychiatric hospital and a detention centre in Taipei, and were assessed with the Diagnostic Interview for Genetic Studies (DIGS). Their parents were interviewed with the Premorbid Schizoid and Schizotypal Traits (PSST) and the Premorbid Social Adjustment (PSA) schedules. Pre-morbid characteristics and psychiatric co-morbidity were compared between the MAMP users with a lifetime diagnosis of MAMP psychosis and those without.
Results:
The MAMP users with psychosis presented a clinical picture which mimicked the positive symptoms of schizophrenia: 85% had auditory hallucinations; 71% persecutory delusions; 63% delusions of reference. Compared with their non-psychotic counterparts, these MAMP users were younger at first MAMP use, used larger amounts of MAMP, had a significantly higher mean PSST score, and higher rates of major depressive disorder, alcohol dependence and antisocial personality disorder.
Conclusions:
Earlier and larger use of MAMP was associated with increased risk of psychosis. Our data are also compatible with the view that pre-morbid schizoid/schizotypal personality predisposes MAMP users to develop psychosis, and that the greater the personality vulnerability, the longer the psychosis will persist.
Insights
Methamphetamine (MAMP) psychosis risk increases with earlier and heavier use. Pre-existing schizoid/schizotypal traits may predispose users to psychosis, with greater vulnerability leading to longer-lasting symptoms.
Area of Science:
- Psychiatry
- Neuroscience
- Addiction Medicine
Background:
- Long-term methamphetamine (MAMP) use can lead to psychosis, but individual susceptibility varies.
- Factors influencing the development of MAMP-induced psychosis remain unclear.
- This study investigates pre-morbid characteristics and psychiatric comorbidities in MAMP users with and without psychosis.
Purpose of the Study:
- To characterize methamphetamine users.
- To examine the relationship between pre-morbid personality, social function, and psychiatric disorders and the development of MAMP psychosis.
- To identify risk factors for MAMP-induced psychosis.
Main Methods:
- Recruited 445 amphetamine users from a psychiatric hospital and detention center in Taipei.
- Assessed participants using the Diagnostic Interview for Genetic Studies (DIGS).
- Interviewed parents using Premorbid Schizoid and Schizotypal Traits (PSST) and Premorbid Social Adjustment (PSA) schedules to compare pre-morbid characteristics and psychiatric comorbidities between MAMP users with and without psychosis.
Main Results:
- MAMP users with psychosis exhibited symptoms mimicking schizophrenia, including auditory hallucinations (85%), persecutory delusions (71%), and delusions of reference (63%).
- Compared to non-psychotic users, those with psychosis were younger at first MAMP use, used larger MAMP amounts, and had higher mean PSST scores.
- MAMP users with psychosis also showed higher rates of major depressive disorder, alcohol dependence, and antisocial personality disorder.
Conclusions:
- Earlier and heavier methamphetamine use is associated with an increased risk of psychosis.
- Pre-morbid schizoid/schizotypal personality traits appear to predispose MAMP users to psychosis.
- Greater personality vulnerability may correlate with longer psychosis persistence.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Psychological and Sociocultural Causes of Schizophrenia

